Kolumne, ORE

Original-Research: Netfonds AG - von NuWays AG Einstufung von NuWays AG zu Netfonds AG Unternehmen: Netfonds AG ISIN: DE000A1MME74 Anlass der Studie: Update Empfehlung: BUY seit: 19.01.2024 Kursziel: 71.00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Frederik Jarchow Strategic acquisition to improve profitability; chg Yesterday, Netfonds announced to have acquired a majority stake in "Meine Finanzkanzlei GmbH" ("MFK") through its fully owned subsidiary NVS Netfonds Versicherungsservice AG.

19.01.2024 - 09:02:31

Original-Research: Netfonds AG (von NuWays AG): BUY


Original-Research: Netfonds AG - von NuWays AG

Einstufung von NuWays AG zu Netfonds AG

Unternehmen: Netfonds AG
ISIN: DE000A1MME74

Anlass der Studie: Update
Empfehlung: BUY
seit: 19.01.2024
Kursziel: 71.00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Frederik Jarchow

Strategic acquisition to improve profitability; chg
 
Yesterday, Netfonds announced to have acquired a majority stake in "Meine
Finanzkanzlei GmbH" ("MFK") through its fully owned subsidiary NVS Netfonds
Versicherungsservice AG. In detail:
 
We assume that Netfonds has acquired a stake of 65-85% (eNuW) at a low to
mid, single digit EV/EBITDA multiple (eNuW). As the network of advisors
from MFK has already been cooperating with NVS for many years, we do not
expect a significant increase of gross sales. Stand alone, MFK should
generate gross sales of c. EUR 1.5-2.0m (eNuW). Due to synergy effects, we
expect a positive EBITDA effect of some EUR 0.3-0.5m (eNuW).
 
Importantly, MFK is actively supporting NVS in customer advice for banks
that are affiliated with NVS. These services are increasingly important for
banks, hence providing a significant growth potential for Netfonds going
forward.
 
Overall, we consider the acquisition as highly value accretive. While the
price should have been absolutely reasonable, MFK is seen to strengthen the
insurance division of Netfonds and contributing to its profitability.
 
More positive newsflow comes from IGBCE Bonusagentur, which extended its
cooperation agreement with NVS in connection with the acquisition of MFK.
With that, NVS keeps its access to more than 3m potential CareFlex
customers. As a strategic partner of IGBCE, MFK should support NVS in the
distribution of CareFlex by advising selected private and corporate
customers.
 
Apart from the value accretive acquisition, Netfonds proprietary, 360

finfire platform, which enables onboarded advisors to offer a wide range ofinvestment, insurance, financing and banking solutions to its customers viaone holistic platform, remains the companyŽs key mid- to long-term growthand scalability driver and should start to lift off in FY24.

That, paired with 1) Netfonds market leading position in an oligopolisticmarket with high entry barriers and long-term structural growth drivers(growing AuMŽs and number of advisors, ongoing digitization of thefinancial sector, stricter regulation), 2) the likely guidance beat in FY23and 3) the promising mid-term guidance makes the stock a clear BUY with anew PT of EUR 71.00, based on DCF.

Die vollständige Analyse können Sie hier downloaden:http://www.more-ir.de/d/28709.pdfDie Analyse oder weiterführende Informationen zu dieser können Sie hier downloadenwww.nuways-ag.com/research.

Kontakt für RückfragenNuWays AG - Equity ResearchWeb: www.nuways-ag.comEmail: research@nuways-ag.comLinkedIn: https://www.linkedin.com/company/nuwaysagAdresse: Mittelweg 16-17, 20148 Hamburg, Germany++++++++++Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------

Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatungoder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

°

@ dpa.de

Weitere Meldungen

Original-Research: ParTec AG (von First Berlin Equity Research GmbH): Buy Original-Research: ParTec AG - from First Berlin Equity Research GmbH 22.11.2024 / 11:20 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 11:21) weiterlesen...

Original-Research: Cardiol Therapeutics Inc (von First Berlin Equity Research... Original-Research: Cardiol Therapeutics Inc - from First Berlin Equity Research GmbH 22.11.2024 / 11:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 11:06) weiterlesen...

Original-Research: ad pepper media International N.V. (von First Berlin Equit... Original-Research: ad pepper media International N.V. - from First Berlin Equity Research GmbH 22.11.2024 / 10:45 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 10:46) weiterlesen...

Original-Research: NFON AG (von NuWays AG): Buy Original-Research: NFON AG - from NuWays AG 22.11.2024 / 09:05 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:06) weiterlesen...

Original-Research: Nabaltec AG (von NuWays AG): Buy Original-Research: Nabaltec AG - from NuWays AG 22.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:02) weiterlesen...

Original-Research: mVISE AG (von NuWays AG): Buy Original-Research: mVISE AG - from NuWays AG 22.11.2024 / 09:01 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. (Boerse, 22.11.2024 - 09:01) weiterlesen...